US Hematology and Flow Cytometry Instruments and Reagents: Supplier Sales and Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, New Technologies, Instrumentation Review, Emerging Opportunities
Complete report $9,850. DataPack (test volumes, sales forecasts, supplier shares) $6,400.
VPGMarketResearch.com new study is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the U.S. hematology and flow cytometry markets during the next five years.
The report explores business and technological trends in the U.S. market; provides market share estimates, as well as specimen, test, sales forecasts, and instrument placements; compares features of major analyzers; profiles leading competitors and emerging market entrants; and suggests specific product and marketing opportunities facing reagent and instrument suppliers.
Rationale
During the next five years, continued advances in molecular diagnostics, monoclonal antibodies, lasers and IT, as well as growing understanding of immunologic forces regulating systemic diseases, will have a profound impact on the hematology and flow cytometry markets worldwide. New molecular diagnostic and monoclonal antibody tests will facilitate existing procedures and provide basis for sensitive, specific and simple assays. The introduction of smaller and easy-to-operate laser systems will further expand applications of flow cytometry to routine clinical laboratories. Further advances in IT will reduce the cost of instrument manufacture, service warranty, and permit development of self-troubleshooting, autocalibration and other advanced features. Presently tedious analyses of chromosomal abnormalities, DNA content, and lymphocyte subsets will become more automated and routine.
U.S. Market Overview
CBC + 5-Part Differential, Manual Differential/Review, Hematocrit (Automated, Manual), Hemoglobin (Automated, Manual), Sedimentation Rate, Reticulocytes, WBC (Automated, Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils.
Flow Cytometry Tests
Cell Surface Markers (CD4/CD8/T&B Lymphocytes, CD34, Others), Chemotherapy Monitoring (Leukemia/Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/RNA Analysis, Cell Culturing.
Current and Emerging Products
Extensive strategic profiles of major suppliers and emerging market entrants.
The companies analyzed in the report include:
VPGMarketResearch.com new study is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the U.S. hematology and flow cytometry markets during the next five years.
The report explores business and technological trends in the U.S. market; provides market share estimates, as well as specimen, test, sales forecasts, and instrument placements; compares features of major analyzers; profiles leading competitors and emerging market entrants; and suggests specific product and marketing opportunities facing reagent and instrument suppliers.
Rationale
During the next five years, continued advances in molecular diagnostics, monoclonal antibodies, lasers and IT, as well as growing understanding of immunologic forces regulating systemic diseases, will have a profound impact on the hematology and flow cytometry markets worldwide. New molecular diagnostic and monoclonal antibody tests will facilitate existing procedures and provide basis for sensitive, specific and simple assays. The introduction of smaller and easy-to-operate laser systems will further expand applications of flow cytometry to routine clinical laboratories. Further advances in IT will reduce the cost of instrument manufacture, service warranty, and permit development of self-troubleshooting, autocalibration and other advanced features. Presently tedious analyses of chromosomal abnormalities, DNA content, and lymphocyte subsets will become more automated and routine.
U.S. Market Overview
- Facilities performing hematology and flow cytometry testing.
- Test volume and sales projections.
- New product development opportunities with significant market appeal.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
- Sales and market share estimates for leading suppliers of hematology and flow cytometry products by country.
- Specimen, test and sales forecasts for over 40 procedures by individual test and market segment:
- Hospitals
- Commercial/Private Laboratories
- Physician Offices/Group Practices
- Sales and market shares of major instrument and reagent suppliers.
CBC + 5-Part Differential, Manual Differential/Review, Hematocrit (Automated, Manual), Hemoglobin (Automated, Manual), Sedimentation Rate, Reticulocytes, WBC (Automated, Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils.
Flow Cytometry Tests
Cell Surface Markers (CD4/CD8/T&B Lymphocytes, CD34, Others), Chemotherapy Monitoring (Leukemia/Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/RNA Analysis, Cell Culturing.
Current and Emerging Products
- Analysis of current and emerging hematology and flow cytometry assays.
- Reagent and instrument sales forecasts by market segment.
- Instrument placements and installed base by manufacturer and model.
- Sales and market shares of reagent and instrument suppliers.
- The study reviews current instrumentation technologies, and compares features of leading hematology, flow cytometry, platelet aggregation and sedimentation rate analyzers.
- The report features analyzers manufactured by Abbott, Beckman Coulter/Danaher, Becton Dickinson, Biocode Hycel, CellaVision, Diesse Ves Matic, Drew-Scientific, Horiba, Medica, Menarini, Nihon Kohden, Polymedco, Siemens and Sysmex.
- Assessment of current and emerging technologies and their potential market applications.
- Comprehensive lists of companies developing or marketing new technologies and products by test.
Extensive strategic profiles of major suppliers and emerging market entrants.
The companies analyzed in the report include:
- Abbott
- Agilent Technologies
- Beckman Coulter/Danaher
- Becton Dickinson
- Bio-Rad
- CellaVision
- Horiba
- Iris Diagnostics/Danaher
- Nihon Kohden
- Ortho-Clinical Diagnostics
- Roche
- Siemens
- Sysmex
I. INTRODUCTION
II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Routine and Special Hematology Tests
1. Introduction
2. CBC Analysis
a. Hemoglobin Concentration
b. Hematocrit Determination
c. Red Blood Cell Count
d. Red Cell Indices
MCV
RDW
MCHC
CHCM
HDW
MCH
e. Red Cell Size Histograms
f. Platelets
Platelet Count
Platelet Size/MPV
PDW
Automated Systems
g. Reticulocytes
3. White Blood Cell Analysis
a. WBC Count
b. Five-Partial Differential Major Suppliers
Abbott
Beckman Coulter/Danaher
Siemens
Sysmex
c. Pattern Recognition Systems
IRIS
d. Comparison of Major Differential Analyzers
4. Reticulocytes
5. Platelet Function Tests
6. Erythrocyte Sedimentation Rate/CRP
7. Red Cell Analysis
8. 2, 3 DPG
9. Red Cell Deformability
10. Neutrophil Function Tests
11. Semen Analysis
12. Bone Marrow Analysis
13. Urinalysis
B. Major Flow Cytometry Applications
1. Cell Surface Markers
a. Lymphocyte Subclassification CD4/CD8
Instrumentation and Reagent Test Kits
BD
Beckman Coulter/Danaher
T Cells Diagnostics
b. Other Cell Markers
2. DNA Content Analysis
3. RNA Content Analysis
4. Chemotherapy Monitoring
5. Cell Cycle Analysis
6. Chromosome Analysis
7. Fetal Cell Analysis
8. HLA Typing
9. Microbiology
10. Protein Content Analysis
11. Multiparameter Analysis
12. Other Applications
C. Instrumentation Review
1. Hematology Analyzers
a. Overview
Electrical Aperture-Impedance Analyzers
Light Scatter Analyzers
b. System Review
Abbott
Beckman Coulter/Danaher
Biocode Hycel
Drew-Scientific
Horiba
Menarini
Nihon Kohden
Siemens
Sysmex
2. Flow Cytometers
a. Introduction
b. System Overview
Becton Dickinson
Beckman Coulter/Danaher
3. Platelet Aggregometers
4. Sedimentation Rate Analyzers
Diesse Ves Matic
Polymedco
D. Current Market Needs and Future Demand For Hematology Analyzers
E. Reagents and Controls
F. Current and Emerging Technologies
1. Information Technologies
2. Automation and Robotics
3. Lasers
4. Artificial Intelligence
5. Monoclonal Antibodies
6. Molecular Diagnostics
7. Microdrop Technology
IX. U.S.
A. Executive Summary
B. Business Environment
1. Health Care Expenditures
2. Cost Consciousness
3. Reimbursement
4. Industry Consolidation
5. Managed Care
a. HMO
b. PPO
6. Hospitals
7. Admissions
8. Length of Stay
9. Industry Diversification
10. Physician Demographics
11. Population Aging
a. Chronic Illness
b. Disease Incidence
c. Susceptibility to Iatrogenesis
d. Multiple Illness Cases
12. Laboratory Regulations
C. Market Structure
D. Market Size, Growth and Major Suppliers’ Instrument Placements, Installed Base, Sales and Market Shares
X. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
XI. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
XII. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for the Decentralized Testing Markets
1. Four Marketing Approaches
2. Product Complexity Factor
3. Customer Preference Factor
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation Factor
XIII. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XIV. COMPETITIVE ASSESSMENTS
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Bio-Rad
CellaVision
Dako
Horiba
Iris
Nihon Kohden
Ortho-Clinical Diagnostics
Roche
Siemens
Sysmex
XV. APPENDIX: MAJOR UNIVERSITIES AND RESEARCH CENTERS DEVELOPING HEMATOLOGY/FLOW CYTOMETRY TECHNOLOGIES AND APPLICATIONS
II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Routine and Special Hematology Tests
1. Introduction
2. CBC Analysis
a. Hemoglobin Concentration
b. Hematocrit Determination
c. Red Blood Cell Count
d. Red Cell Indices
MCV
RDW
MCHC
CHCM
HDW
MCH
e. Red Cell Size Histograms
f. Platelets
Platelet Count
Platelet Size/MPV
PDW
Automated Systems
g. Reticulocytes
3. White Blood Cell Analysis
a. WBC Count
b. Five-Partial Differential Major Suppliers
Abbott
Beckman Coulter/Danaher
Siemens
Sysmex
c. Pattern Recognition Systems
IRIS
d. Comparison of Major Differential Analyzers
4. Reticulocytes
5. Platelet Function Tests
6. Erythrocyte Sedimentation Rate/CRP
7. Red Cell Analysis
8. 2, 3 DPG
9. Red Cell Deformability
10. Neutrophil Function Tests
11. Semen Analysis
12. Bone Marrow Analysis
13. Urinalysis
B. Major Flow Cytometry Applications
1. Cell Surface Markers
a. Lymphocyte Subclassification CD4/CD8
Instrumentation and Reagent Test Kits
BD
Beckman Coulter/Danaher
T Cells Diagnostics
b. Other Cell Markers
2. DNA Content Analysis
3. RNA Content Analysis
4. Chemotherapy Monitoring
5. Cell Cycle Analysis
6. Chromosome Analysis
7. Fetal Cell Analysis
8. HLA Typing
9. Microbiology
10. Protein Content Analysis
11. Multiparameter Analysis
12. Other Applications
C. Instrumentation Review
1. Hematology Analyzers
a. Overview
Electrical Aperture-Impedance Analyzers
Light Scatter Analyzers
b. System Review
Abbott
Beckman Coulter/Danaher
Biocode Hycel
Drew-Scientific
Horiba
Menarini
Nihon Kohden
Siemens
Sysmex
2. Flow Cytometers
a. Introduction
b. System Overview
Becton Dickinson
Beckman Coulter/Danaher
3. Platelet Aggregometers
4. Sedimentation Rate Analyzers
Diesse Ves Matic
Polymedco
D. Current Market Needs and Future Demand For Hematology Analyzers
E. Reagents and Controls
F. Current and Emerging Technologies
1. Information Technologies
2. Automation and Robotics
3. Lasers
4. Artificial Intelligence
5. Monoclonal Antibodies
6. Molecular Diagnostics
7. Microdrop Technology
IX. U.S.
A. Executive Summary
B. Business Environment
1. Health Care Expenditures
2. Cost Consciousness
3. Reimbursement
4. Industry Consolidation
5. Managed Care
a. HMO
b. PPO
6. Hospitals
7. Admissions
8. Length of Stay
9. Industry Diversification
10. Physician Demographics
11. Population Aging
a. Chronic Illness
b. Disease Incidence
c. Susceptibility to Iatrogenesis
d. Multiple Illness Cases
12. Laboratory Regulations
C. Market Structure
D. Market Size, Growth and Major Suppliers’ Instrument Placements, Installed Base, Sales and Market Shares
X. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
XI. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
XII. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for the Decentralized Testing Markets
1. Four Marketing Approaches
2. Product Complexity Factor
3. Customer Preference Factor
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation Factor
XIII. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XIV. COMPETITIVE ASSESSMENTS
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Bio-Rad
CellaVision
Dako
Horiba
Iris
Nihon Kohden
Ortho-Clinical Diagnostics
Roche
Siemens
Sysmex
XV. APPENDIX: MAJOR UNIVERSITIES AND RESEARCH CENTERS DEVELOPING HEMATOLOGY/FLOW CYTOMETRY TECHNOLOGIES AND APPLICATIONS
LIST OF TABLES
Summary Table I: U.S., All Market Segments, Total Hematology and Flow Cytometry Specimen Volume Forecast
Summary Table II: U.S., All Market Segments, Total Hematology and Flow Cytometry Test Volume Forecast
Summary Table III: U.S., All Market Segments, Total Hematology and Flow Cytometry Market Forecast
U.S., Laboratories Performing Hematology/Flow Cytometry Testing By Market Segment
U.S., Hospital Laboratories Performing Hematology and Flow Cytometry Tests By Bed Size
U.S., Commercial/Private Laboratories Performing Hematology/Flow Cytometry Tests By Annual Test Volume
U.S., Physician Offices/Group Practices Performing Hematology/Flow Cytometry Tests By Annual Test Volume
U.S., Total Routine Hematology Specimen Volume Forecast By Market Segment
U.S., Total Flow Cytometry and Special Hematology Specimen Volume Forecast By Market Segment
U.S., Hospital Laboratories, Hematology And Flow Cytometry Specimen Volume Forecast
U.S., Physician Offices/Group Practices, Hematology And Flow Cytometry Specimen Volume Forecast
U.S., Commercial/Private Laboratories, Hematology and Flow Cytometry Specimen Volume Forecast
U.S., Total Routine Hematology Test Volume Forecast By Market Segment
U.S., Total Flow Cytometry and Special Hematology Test Volume Forecast By Market Segment
U.S., All Market Segments, Total Routine Hematology Test Volume Forecast
U.S., Hospital Laboratories, Routine Hematology Test Volume Forecast
U.S., Commercial/Private Laboratories, Routine Hematology Test Volume Forecast
U.S., Physician Office Laboratories, Routine Hematology Test Volume Forecast
U.S., All Market Segments, Flow Cytometry and Special Hematology Test Volume Forecast
U.S., Hospital Laboratories, Flow Cytometry and Special Hematology Test Volume Forecast
U.S., Commercial/Private Laboratories, Flow Cytometry and Special Hematology Test Volume Forecast
U.S., Physician Office Laboratories, Flow Cytometry and Special Hematology Test Volume Forecast
U.S., Major Hematology Analyzers, Estimated Placements and Installed Base
U.S., Major Flow Cytometers, Estimated Placements and Installed Base
U.S., Total Hematology Market By Market Segment Forecast
U.S., Hematology Instrument Market By Markets Segment Forecast
U.S., Hematology Consumable Market By Market Segment Forecast
U.S., Total Flow Cytometry Market Forecast By Market Segment
U.S., Flow Cytometry Consumable Market Forecast By Market Segment
U.S., Flow Cytometry Instrument Market Forecast By Market Segment
U.S., Total Hematology Market By Major Supplier
U.S., Hematology Instrument Market By Major Supplier
U.S., Hematology Consumable Market By Major Supplier
U.S., Total Flow Cytometry Market By Major Supplier
U.S., Total Flow Cytometry Consumable Market By Major Supplier
U.S., Total Flow Cytometry Instrument Market By Major Supplier
Summary Table I: U.S., All Market Segments, Total Hematology and Flow Cytometry Specimen Volume Forecast
Summary Table II: U.S., All Market Segments, Total Hematology and Flow Cytometry Test Volume Forecast
Summary Table III: U.S., All Market Segments, Total Hematology and Flow Cytometry Market Forecast
U.S., Laboratories Performing Hematology/Flow Cytometry Testing By Market Segment
U.S., Hospital Laboratories Performing Hematology and Flow Cytometry Tests By Bed Size
U.S., Commercial/Private Laboratories Performing Hematology/Flow Cytometry Tests By Annual Test Volume
U.S., Physician Offices/Group Practices Performing Hematology/Flow Cytometry Tests By Annual Test Volume
U.S., Total Routine Hematology Specimen Volume Forecast By Market Segment
U.S., Total Flow Cytometry and Special Hematology Specimen Volume Forecast By Market Segment
U.S., Hospital Laboratories, Hematology And Flow Cytometry Specimen Volume Forecast
U.S., Physician Offices/Group Practices, Hematology And Flow Cytometry Specimen Volume Forecast
U.S., Commercial/Private Laboratories, Hematology and Flow Cytometry Specimen Volume Forecast
U.S., Total Routine Hematology Test Volume Forecast By Market Segment
U.S., Total Flow Cytometry and Special Hematology Test Volume Forecast By Market Segment
U.S., All Market Segments, Total Routine Hematology Test Volume Forecast
U.S., Hospital Laboratories, Routine Hematology Test Volume Forecast
U.S., Commercial/Private Laboratories, Routine Hematology Test Volume Forecast
U.S., Physician Office Laboratories, Routine Hematology Test Volume Forecast
U.S., All Market Segments, Flow Cytometry and Special Hematology Test Volume Forecast
U.S., Hospital Laboratories, Flow Cytometry and Special Hematology Test Volume Forecast
U.S., Commercial/Private Laboratories, Flow Cytometry and Special Hematology Test Volume Forecast
U.S., Physician Office Laboratories, Flow Cytometry and Special Hematology Test Volume Forecast
U.S., Major Hematology Analyzers, Estimated Placements and Installed Base
U.S., Major Flow Cytometers, Estimated Placements and Installed Base
U.S., Total Hematology Market By Market Segment Forecast
U.S., Hematology Instrument Market By Markets Segment Forecast
U.S., Hematology Consumable Market By Market Segment Forecast
U.S., Total Flow Cytometry Market Forecast By Market Segment
U.S., Flow Cytometry Consumable Market Forecast By Market Segment
U.S., Flow Cytometry Instrument Market Forecast By Market Segment
U.S., Total Hematology Market By Major Supplier
U.S., Hematology Instrument Market By Major Supplier
U.S., Hematology Consumable Market By Major Supplier
U.S., Total Flow Cytometry Market By Major Supplier
U.S., Total Flow Cytometry Consumable Market By Major Supplier
U.S., Total Flow Cytometry Instrument Market By Major Supplier
